Exit Strategy: Biopharma Professionals Consider Opportunities Outside Industry and US
A May 2025 BioSpace survey found that 56% of employed and 81% of unemployed biopharma professionals are considering jobs outside the biopharma industry.
Less than half of survey respondents are seriously considering leaving the US for biopharma employment, with unemployed individuals more likely to consider this option.
There has been a significant increase in job candidates inquiring about switching industries or working abroad, a 340-fold jump over four years according to Bryan Blair of GQR.
From an employer standpoint, concerns about employees leaving biopharma or the US are less pronounced, with more focus on federal policy impacts such as NIH funding cuts and drug pricing regulations.
The current US political and regulatory environment, including the Trump administration’s policies, contributes to uncertainty in the biopharma sector, possibly influencing talent considerations and industry dynamics.